Schilling Test Interpretation

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

Schillling test

Potential Diagnosis

During Stage 1, a healthy person will be able to absorb the administered radioactive B12 in their
terminal ileum. It will then be excreted in the urine.

If there are any defects with the cubam receptor at the terminal ileum, the result will show a low level of
labeled cobalamin in urine as it will remain in the intestines and is likely to be excreted in feces. A defect
associated with low levels of an intrinsic factor will also produce a similar abnormal result.

Patients with an abnormally low level of cobalamin in the urine in stage 1 usually undergo stage 2. If
stage 2 shows a normal level of excreted vitamin B12, it means that the patient has low intrinsic factor
levels, and one possible cause is pernicious anemia. If the test still indicates a low level of vitamin B12 in
the urine, it means that the patient has a poor intestinal absorption of cobalamin. Further tests should
be done to assess the cause of malabsorption that can include Crohn’s disease, small bowel bacterial
overgrowth syndrome, and infection by Diphyllobothrium latum.

Normal and Critical findings

Stage 1

A normal patient will show a normal level of cobalamin in urine upon administration of the oral dose. If
the urine level is abnormal, it can be from either an absorption defect in the terminal ileum or a lack of
intrinsic factor.

Excreting 8% to 40% of the radioactive vitamin B12 in the urine within 24 hours is considered a normal
finding. The values, however, may fluctuate between laboratories.

Stage 2

If the abnormal result of stage 1 improves with intrinsic factor administration, it means that the patient
has intrinsic factor deficiency. If the patient still has a low urine level of cobalamin, then there is an
absorption defect in the terminal ileum, and further tests should be done to investigate.
Additionally

Currently, the Schilling test is not readily available in most countries to diagnose vitamin B12 deficiency.
Labeled cobalamine can no longer be obtained. No replacement test provides the same information, but
the level of serum vitamin B12 is now a test of choice in many hospitals. Patients with >300 pg/mL are
normal, 200 to 300 pg/mL borderline and less than 200 pg/mL classified as deficient in vitamin B12. The
levels of homocysteine and methylmalonic acid are also usually investigated and elevated in those
patients. Other options are the CobaSorb test that measures changes in circulating holo-transcobalamin
before and after B-12 administration, and the 14C-labeled B-12 test for quantitative measurement of
absorption of a low-dose radioactive tracer.

Patients with low levels of cobalamin are tested for autoantibodies to intrinsic factor with an
immunoassay. Pernicious anemia is usually caused by the presence of autoantibodies against parietal
cells that make intrinsic factors, and the presence of those autoantibodies is considered as a
confirmatory test. The immunoassay has low sensitivity and specificity, and if the physician suspects
pernicious anemia and has a negative immunoassay, it is advised to measure gastrin levels. Since
parietal cells are also responsible for the production of gastrin level, patients with pernicious anemia will
also have a low gastrin level.

References:

Rao SK,Schilling TF,Sequist TD, Challenges in the management of positive fecal occult blood tests.
Journal of general internal medicine. 2009 Mar;

Duerksen DR,Fallows G,Bernstein CN, Vitamin B12 malabsorption in patients with limited ileal resection.
Nutrition (Burbank, Los Angeles County, Calif.). 2006 Nov-Dec

https://www.statpearls.com/articlelibrary/viewarticle/28752/

You might also like